| Name | 1-(4-bromophenyl)-3-(4-fluorophenyl)prop-2-en-1-one | 
|---|---|
| Synonyms | 2-Propen-1-one,1-(4-bromophenyl)-3-(4-fluorophenyl) 4-Fluoro-4'-bromochalcone | 
| Description | CHBO4 is a potent, reversible, competitive, and selective hMAO-B inhibitor with an IC50 value of 0.031 μM in CHBO subseries and an Ki value of 0.010 ± 0.005 μM. CHBO4 reduce cell damage by scavenging intracellular reactive oxygen species (ROS). CHBO4 can be used for Parkinson's Disease (PD) research[1]. | 
|---|---|
| Related Catalog | |
| Target | hMAO-B:0.031 μM (IC50) hMAO-B:0.010 μM (Ki) | 
| References | 
| Molecular Formula | C15H10BrFO | 
|---|---|
| Molecular Weight | 305.14 | 
| Exact Mass | 303.99000 | 
| PSA | 17.07000 | 
| LogP | 4.48430 | 
| ~98%   98991-32-3 | 
| Literature: Tiwari, Urvashi; Ameta, Chetna; Rawal, Manish K.; Ameta, Rakshit; Punjabi, Pinki B. Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2013 , vol. 52, # 3 p. 432 - 439 | 
| ~18%   98991-32-3 
                                Detail
                                
                                
                             | 
| Literature: El-Bayouki; Basyouni; El-Sayed; Tohamy; El-Henawy Croatica Chemica Acta, 2012 , vol. 85, # 3 p. 255 - 268 | 
| ~18%   98991-32-3 
                                Detail
                                
                                
                             | 
| Literature: El-Bayouki; Basyouni; El-Sayed; Tohamy; El-Henawy Croatica Chemica Acta, 2012 , vol. 85, # 3 p. 255 - 268 |